BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ciocchini M, Arbelbide J, Musso CG. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity. Int Urol Nephrol 2017;49:2171-5. [DOI: 10.1007/s11255-017-1594-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Li JP, Du YT, Li S, Rao XR. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine. Chin J Integr Med 2021. [PMID: 34105098 DOI: 10.1007/s11655-021-3446-y] [Reference Citation Analysis]
2 Wang CH, Hogan JJ. Monoclonal Gammopathies and Kidney Disease: Searching for Significance. Clin J Am Soc Nephrol 2018;13:1781-2. [PMID: 30442863 DOI: 10.2215/CJN.12401018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Smirnov AV, Afanasyev BV, Poddubnaya IV, Dobronravov VA, Khrabrova MS, Zakharova EV, Nikitin EA, Lysenko Kozlovskaya LV, Bobkova IN, Rameev VV, Batyushin MM, Moiseev IS, Darskaya EI, Pirogova OV, Mendeleeva LP, Biryukova LS. [Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment]. Ter Arkh 2020;92:10-22. [PMID: 33346441 DOI: 10.26442/00403660.2020.07.000659] [Reference Citation Analysis]
4 Ciocchini M, Musso CG. What is the place of POEMS syndrome in the current classification of monoclonal gammopathies of renal significance? Int Urol Nephrol 2018;50:383-4. [DOI: 10.1007/s11255-017-1739-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Steiner N, Göbel G, Suchecki P, Prokop W, Neuwirt H, Gunsilius E. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients. Oncotarget 2018;9:2344-56. [PMID: 29416776 DOI: 10.18632/oncotarget.23412] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
6 Tang X, Wan F, Yu J, Li X, Yang R, Zhu B. Clinicopathological characteristics of patients with paraproteinemia and renal damage. Eur J Med Res 2021;26:68. [PMID: 34217367 DOI: 10.1186/s40001-021-00538-2] [Reference Citation Analysis]
7 Yong ZH, Yu XJ, Liu JX, Zhou FD, Wang SX, Zhao MH. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS. Clin J Am Soc Nephrol 2022:CJN. [PMID: 35210280 DOI: 10.2215/CJN.12890921] [Reference Citation Analysis]
8 Ciocchini M, Musso CG. Why renal biopsy is crucial in monoclonal gammopathy of renal significance (MGRS). Int Urol Nephrol 2019;51:899-900. [DOI: 10.1007/s11255-019-02131-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Clari R, Tarella C, Giraudi R, Torazza MC, Gallo E, Lavacca A, Fop F, Mella A, Dolla C, Biancone L. Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome. Clin Kidney J 2021;14:317-24. [PMID: 33564434 DOI: 10.1093/ckj/sfaa105] [Reference Citation Analysis]
10 Iltar U. Comment on "Immunophenotypic profile and clinical outcome of monoclonal B-cell lymphocytosis in kidney transplantation''. Clin Transplant 2018;32:e13403. [PMID: 30264505 DOI: 10.1111/ctr.13403] [Reference Citation Analysis]
11 Jain A, Haynes R, Kothari J, Khera A, Soares M, Ramasamy K. Pathophysiology and management of monoclonal gammopathy of renal significance. Blood Adv 2019;3:2409-23. [PMID: 31409583 DOI: 10.1182/bloodadvances.2019031914] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
12 Cao Q, Qi H, Yao L, Liu Q. Monoclonal gammopathy of renal significance: clinical manifestation, pathogenic characteristic and treatment. Panminerva Med 2020;62:38-53. [PMID: 30848114 DOI: 10.23736/S0031-0808.19.03609-7] [Reference Citation Analysis]
13 Ciocchini M, Musso CG. Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy? Int Urol Nephrol 2018;50:1365-6. [PMID: 29808447 DOI: 10.1007/s11255-018-1896-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Malhotra R, Guleria P, Barwad A, Pramanik R, Tandon N. A unique case of light chain (AL) amyloidosis masquerading as hypophosphatemic osteomalacia. Osteoporos Int 2021;32:387-92. [PMID: 32910218 DOI: 10.1007/s00198-020-05622-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lamb MJ, Smith A, Painter D, Kane E, Bagguley T, Newton R, Howell D, Cook G, de Tute R, Rawstron A, Patmore R, Roman E. Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort. BMJ Open 2021;11:e041296. [PMID: 33619185 DOI: 10.1136/bmjopen-2020-041296] [Reference Citation Analysis]
16 Batko K, Malyszko J, Jurczyszyn A, Vesole DH, Gertz MA, Leleu X, Suska A, Krzanowski M, Sułowicz W, Malyszko JS, Krzanowska K. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance. Nephrol Dial Transplant 2019;34:1440-52. [PMID: 30169860 DOI: 10.1093/ndt/gfy259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]